Psoriatic Arthritis Trial, Recruiting NCT06583980 Sponsor: The Danish Center for Expertise in Rheumatology Condition: Psoriatic Arthritis
Back to Psoriatic Arthritis

Psoriatic Arthritis Trial, Recruiting

NCT06583980
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with rheumatoid arthritis (RA), psoriatic arthritis (PsA), or axial spondyloarthritis (axSpA) by a specialist for at least 2 years, and have been a patient at one of the participating hospital rheumatology departments for at least 2 years
  • You feel that your current symptom levels over the past 48 hours would not be acceptable to you if they continued for the next few months, OR
  • You rate your fatigue, pain, or overall impact of your disease at 60 or more out of 100 on a self-reported scale

Who may not be able to join:

  • Your arthritis medication (DMARDs) or steroid treatment has changed in the past 3 months, or a change is already planned
  • You are currently taking part in certain other named research studies (confirm with trial site)
  • You are not able to speak and understand Danish well enough to participate without a translator
  • You have an unstable mental health condition, memory or thinking difficulties, or other issues that would affect your ability to fully consent to joining the study
  • You have a current alcohol or drug use disorder recorded in your medical records
  • You are currently pregnant or breastfeeding
  • You are already receiving, or have planned, rehabilitation at specific named Danish rheumatic or pain/sleep clinics (confirm with trial site)
  • You are currently applying for early retirement, or you have planned surgery that will require a hospital stay
  • You did not take part in an earlier related feasibility study, or you are a patient research partner in this trial

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jette Primdahl, PhD, University of Southern Denmark

Phone: 0045 2420 6692

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Danish Center for Expertise in Rheumatology
Registry
ClinicalTrials.gov
Start date
5 September 2024
Est. completion
31 August 2027

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

EQ5D-5L VAS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov